Skip to main content
Top

Breast Cancer Research and Treatment

Issue 3/2002

Content (13 Articles)

Episomally Mediated Overexpression of Wild-Type erbB-2 Transforms MCF-10A Breast Epithelial Cells

Bennett W. Yu, Mark Bowers, Greg Witkowski, Meiyi Huang, Satyabama Ramachandran

(−)-Epigallocatechin (EGC) of Green Tea Induces Apoptosis of Human Breast Cancer Cells But Not of their Normal Counterparts

David Vergote, Cécile Cren-Olivé, Valérie Chopin, Robert-Alain Toillon, Christian Rolando, Hubert Hondermarck, Xuefen Le Bourhis

Expression of MUCI Splice Variants Correlates with Invasive Growth of Breast Cancer Cell Lines

Bernd C. Schmid, Laki Buluwela, QiuYan Liu, Barbara Fasching, Dan Tong, Margit Stimpfl, Obermair Andreas, Sepp Leodolter, Robert Zeillinger

Age-Dependent Changes in Breast Cancer Hormone Receptors and Oxidant Stress Markers

Judy Quong, Serenella Eppenberger-Castori, Dan Moore III, Gary K. Scott, Michael J. Birrer, Willy Kueng, Urs Eppenberger, Christopher C. Benz

Increased False Negative Rates in Sentinel Lymph Node Biopsies in Patients with Multi-Focal Breast Cancer

Vahit Ozmen, Mahmut Muslumanoglu, Neslihan Cabioglu, Sitki Tuzlali, Ridvan Ilhan, Abdullah Igci, Mustafa Kecer, Yavuz Bozfakioglu, Temel Dagoglu

Satisfaction and Anxiety for Women During Investigation of an Abnormal Screening Mammogram

T. Gregory Hislop, Susan R. Harris, Jeremy Jackson, Sally E. Thorne, Eunice J. Rousseau, Andrew J. Coldman, Judith A. Vestrup, Charles J. Wright, Ivo A. Olivotto

Mucinous Cancers have Fewer Genomic Alterations than More Common Classes of Breast Cancer

Hiroaki Fujii, Ramaswamy Anbazhagan, Daniel M. Bornman, Elizabeth S. Garrett, Elizabeth Perlman, Edward Gabrielson

Activation of c-Src is Inversely Correlated with Biological Aggressiveness of Breast Carcinoma

Yasuhiro Ito, Hisaaki Kawakatsu, Tsutomu Takeda, Naoyuki Tani, Naomasa Kawaguchi, Shinzaburo Noguchi, Takao Sakai, Nariaki Matsuura

Authors Index

Author Index, Volume 76

Subject Index

Subject Index, Volume 76

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine